Your browser doesn't support javascript.
loading
Hypertonicity counteracts MCL-1 and renders BCL-XL a synthetic lethal target in head and neck cancer.
Heimer, Sina; Knoll, Gertrud; Neubert, Patrick; Hammer, Karin P; Wagner, Stefan; Bauer, Richard J; Jantsch, Jonathan; Ehrenschwender, Martin.
Afiliação
  • Heimer S; Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Knoll G; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
  • Neubert P; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
  • Hammer KP; Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
  • Wagner S; Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
  • Bauer RJ; Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Jantsch J; Department of Oral and Maxillofacial Surgery, Center for Medical Biotechnology, University Hospital Regensburg, Regensburg, Germany.
  • Ehrenschwender M; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
FEBS J ; 288(6): 1822-1838, 2021 03.
Article em En | MEDLINE | ID: mdl-32710568

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pressão Osmótica / Carcinoma de Células Escamosas / Proteína bcl-X / Proteína de Sequência 1 de Leucemia de Células Mieloides / Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pressão Osmótica / Carcinoma de Células Escamosas / Proteína bcl-X / Proteína de Sequência 1 de Leucemia de Células Mieloides / Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article